TrialCardiovascular diabetology2017

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.

Michio Shimabukuro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.